Author: Dan D. Aridor

I hold an MBA from Columbia Business School (1994) and a BA in Economics and Business Management from Bar-Ilan University (1991). Previously, I served as a Lieutenant Colonel (reserve) in the Israeli Intelligence Corps. Additionally, I have extensive experience managing various R&D projects across diverse technological fields. In 2024, I founded INGA314.com, a platform dedicated to providing professional scientific consultations and analytical insights. I am passionate about history and science fiction, and I occasionally write about these topics.

COVID-19 prenatal infection claims unravel under scientific scrutiny – How a Spanish newspaper falsely attributed population-level claims to research that never made them.

25/08/202525/08/2025

The study that claims to measure “accelerated aging” using Small Numbers, Measurements Problems but Big Claims in Covid Research

17/08/202517/08/2025

The Unthinkable Possibility: Are Vaccines the Problem?

16/08/2025

Endomyocardial Biopsy Limitations: The sensitivity for detecting myocarditis ranges from merely 25% for lymphocytic myocarditis to 35% for cardiac sarcoidosis—meaning negative biopsies cannot rule out pathology while positive findings may represent sampling artifacts.

Author: Dan D. Aridor

The Creatine Cancer “Breakthrough” That Wasn’t: A Scientific Detective Story

The Cysteine Weight Loss Study That Promises Too Much

COVID-19 prenatal infection claims unravel under scientific scrutiny – How a Spanish newspaper falsely attributed population-level claims to research that never made them.

Cross-Validation of VIZZ Eye Drops Claims Against FDA-Submitted Clinical Evidence

Ivermectin as a cancer drug requires major reassessment based on new evidence

The GLP-1 Cancer Study That Got Everything Wrong: What Patients Need to Know

How AI-designed peptides are resurrecting “dead” therapeutics in weeks, not decades

The study that claims to measure “accelerated aging” using Small Numbers, Measurements Problems but Big Claims in Covid Research

The Unthinkable Possibility: Are Vaccines the Problem?

Endomyocardial Biopsy Limitations: The sensitivity for detecting myocarditis ranges from merely 25% for lymphocytic myocarditis to 35% for cardiac sarcoidosis—meaning negative biopsies cannot rule out pathology while positive findings may represent sampling artifacts.